Mesoglycan: Clinical evidences for use in vascular diseases

International Journal of Vascular Medicine

Volumn 2010, Issue , 2010, Pages

  Tufano, Antonella ^a   Arturo, Claudia ^a   Cimino, Ernesto ^a   Di Minno, Matteo Nicola Dario ^a   Di Capua, Mirko ^a   Cerbone, Anna Maria ^a   Di Minno, Giovanni ^a  

^a FEDERICO II UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876469616     PISSN: 20902824     EISSN: 20902832     Source Type: Journal    
DOI: 10.1155/2010/390643     Document Type: Review

References (36)

1. Vittoria A., Messa G. L., Frigerio C., Celasco G., Auteri A., Effect of a single dose of mesoglycan on the human fibrinolytic system, and the profibrinolytic action of nine daily doses. International Journal of Tissue Reactions 1988 10 4 261 266 2-s2.0-0024274657 (Pubitemid 19101384)
2. Maggi A., Abbadini M., Pagella P. G., Borowska A., Pangrazzi J., Donati M. B., Antithrombotic properties of dermatan sulphate in a rat venous thrombosis model. Haemostasis 1987 17 6 329 335 2-s2.0-0023600275 (Pubitemid 18060169)
3. Teien A. N., Abildgaard U., Hook M., The anticoagulant effect of heparin sulfate and dermatan sulfate. Thrombosis Research 1976 8 6 859 867 2-s2.0-0017100871
4. Abbadini M., Zhu G. J., Maggi A., Pangrazzi J., Donati M. B., Mussoni L., Dermatan sulphate induces plasminogen activator release in the perfused rat hindquarters. Blood 1987 70 6 1858 1860 2-s2.0-0023598542 (Pubitemid 18055636)
5. Restori G., Boiardi L., Mari S., Glycosaminoglycans administration (heparan sulphate, dermatan-sulphate and their combinations 50:50) and reduction of atherosclerosis progression rate in rabbits with a diet-induced hypercholesterolemia. Atherosclerosis and Cardiovascular Disease 1989 4 971 975
6. Blajchman M. A., Young E., Ofosu F. A., Effects of unfractionated heparin, dermatan sulfate and low molecular weight heparin on vessel wall permeability in rabbits. Annals of the New York Academy of Sciences 1989 556 245 254 2-s2.0-0024328228 (Pubitemid 19199317)
7. Caimi G., Romandini S., Lo Presti R., Serra A., Montana M., Francavilla G., Sarno A., Effect of mesoglycan on macrorheologic and microrheologic parameters. Current Therapeutic Research 1992 52 3 412 418 2-s2.0-0026788453
8. Viliani T., Scarselli M., Pieri A., Gatti M., Santini M., Pasquetti P., Pharmacological treatment of mechanical edema: a randomized controlled trial about the effects of mesoglycan. European Journal of Physical and Rehabilitation Medicine 2009 45 1 21 29 2-s2.0-67650482351
9. Tardieu M., Bourin M.-C., Desgranges P., Barbier P., Barritault D., Caruelle J.-P., Mesoglycan and sulodexide act as stabilizers and protectors of fibroblast growth factors (FGFs). Growth Factors 1994 11 4 291 300 2-s2.0-0028648301
10. Lotti T., Celasco G., Tsampau D., Teofoli P., Benci M., Dahm M., Comacchi C., Ghersetich I., Matucci-Cerinic M., Mesoglycan treatment restores defective fibrinolytic potential in cutaneous necrotizing venulitis. International Journal of Dermatology 1993 32 5 368 371 2-s2.0-0027273878 (Pubitemid 23156179)
11. Orefice G., Brancaccio V., Coppola G., Iannaccone L., Ascione S., Manchia A., Vacca G., Morra V. B., Comparative effects of mesoglycan and ticlopidine treatment on some coagulative parameters in patients with previous ischemic stroke: results of a randomized controlled trial. Current Therapeutic Research 2002 63 5 337 343 2-s2.0-0036306912 10.1016/S0011-393X(02)80037-6 (Pubitemid 34734797)
12. Orefice G., Troisi E., Selvaggio M., Vecchione V., Rubino S., Provitera V., Carrieri P. B., Effect of long-term mesoglycan treatment on fibrinogen plasma levels in patients with ischemic cerebrovascular disease. Current Therapeutic Research 1992 52 5 666 670 2-s2.0-0026574853 10.1016/S0011-393X(05) 80508-9
13. Vecchio F., Zanchin G., Maggioni F., Santambrogio C., De Zanche L., Mesoglycan in treatment of patients with cerebral ischemia: effects of hemorheologic and hematochemical parameters. Acta Neurologica 1993 48 6 449 456 2-s2.0-0027868056 (Pubitemid 24044539)
14. Mansi D., Sinisi L., De Michele G., Di Geronimo G., Palma V., Morra V. B., Coppola N., Buscaino G. A., Open trial of mesoglycan in the treatment of cerebrovascular ischemic disease. Acta Neurologica 1988 43 2 108 112 2-s2.0-0023987355
15. Forconi S., Battistini N., Guerrini N., Passero G. S., A randomized, ASA-controlled trial of mesoglycan in secondary prevention after cerebral ischemic events. Cerebrovascular Diseases 1995 5 334 341 10.1159/000107878
16. Wilhelmsen L., Svardsudd K., Korsan-Bengtsen K., Fibrinogen as a risk factor for stroke and myocardial infarction. The New England Journal of Medicine 1984 311 8 501 505 2-s2.0-0021210911 (Pubitemid 14059351)
17. Di Minno G., Mancini M., Drugs affecting plasma fibrinogen levels. Cardiovascular Drugs and Therapy 1992 6 1 25 27 2-s2.0-0026589525 10.1007/BF00050913
18. Andreozzi G. M., Signorelli S., Lo Duca S., Minacapelli C., Amico-Roxas M. T., Minardo G., Cacciaguerra G., Effects of mesoglycan sulfate on the arterial elastic module. Angiology 1987 38 8 593 600 2-s2.0-0023616691 (Pubitemid 17154912)
19. Raso A. M., Maggio D., Trogolo M., Effectiveness of mesoglycan therapy in patients with ischemia of the lower limbs. Preliminary results of a new therapeutic protocol. Minerva Cardioangiologica 1997 45 7-8 383 392
20. Nenci G. G., Gresele P., Ferrari G., Santoro L., Gianese F., Treatment of intermittent claudication with mesoglycan-a placebo-controlled, double-blind study. Thrombosis and Haemostasis 2001 86 5 1181 1187 2-s2.0-0035167832 (Pubitemid 33064565)
21. Nakashima Y., Segawa J., Kawashima T., Fukuchi Y., Kuroiwa A., Chronic arterial occlusion with PGE1-resistant skin lesions treated by glycosaminoglycan compound-case reports. Angiology 1990 41 9 731 736 2-s2.0-0025132434 (Pubitemid 20357092)
22. Segawa J., Kawashima T., Yashiro A., Acute effects of intravenous administration of glycosaminoglycans compound (FPFD 101) on healthy volunteers. Journal of Japan Atherosclerosis Society 1988 16 871
23. Arosio E., Ferrari G., Santoro L., Gianese F., A placebo-controlled, double-blind study of mesoglycan in the treatment of chronic venous ulcers. European Journal of Vascular and Endovascular Surgery 2001 22 4 365 372 2-s2.0-0034817233 10.1053/ejvs.2001.1478 (Pubitemid 32923116)
24. Andreozzi G. M., Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency. Minerva Cardioangiologica 2007 55 6 741 753 2-s2.0-38649119103 (Pubitemid 351169837)
25. Viliani T., Scarselli M., Pieri A., Gatti M., Santini M., Pasquetti P., Pharmacological treatment of mechanical edema: a randomized controlled trial about the effects of mesoglycan. European Journal of Physical and Rehabilitation Medicine 2009 45 1 21 29 2-s2.0-67650482351
26. Prandoni P., Cattelan A. M., Carta M., Long-term sequelae of deep-vein thrombosis of the lower limbs. Experience with mesoglycan. Annali Italiani di Medicina Interna 1989 4 4 378 385 2-s2.0-0024892645 (Pubitemid 20137998)
27. Kurz X., Kahn S. R., Abenhaim L., Clement D., Norgren L., Baccaglini U., Berard A., Cooke J. P., Cornu-Thenard A., Depairon M., Dormandy J. A., Durand-Zaleski I., Fowkes G. R., Lamping D. L., Partsch H., Scurr J. H., Zuccarelli F., Chronic venous disorders of the leg: epidemiology, outcomes, diagnosis and management. Summary of an evidence-based report of the VEINES task force. Venous Insufficiency Epidemiologic and Economic Studies. International Angiology 1999 18 2 83 102
28. van de Scheur M., Falanga V., Pericapillary fibrin cuffs in venous disease: a reappraisal. Dermatologic Surgery 1997 23 10 955 959 2-s2.0-0030699465 (Pubitemid 27476117)
29. Penc S. F., Pomahac B., Winkler T., Dorschner R. A., Eriksson E., Herndon M., Gallo R. L., Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function. Journal of Biological Chemistry 1998 273 43 28116 28121 2-s2.0-0032561306 10.1074/jbc.273.43.28116 (Pubitemid 28496107)
30. McGrath J. A., Eady R. A. J., Heparan sulphate proteoglycan and wound healing in skin. Journal of Pathology 1997 183 3 251 252 2-s2.0-0030665449 10.1002/(SICI)1096-9896(199711)183:3<251::AID-PATH969>3.0.CO;2-H (Pubitemid 27505208)
31. Mariani F., Edema of the lower limb: differential diagnosis and therapy. Italian Journal of Practice Cardiology 2004 2 61 69
32. Terry M., O'Brien S. P., Kerstein M. D., Lower-extremity edema: evaluation and diagnosis. Wounds 1998 10 4 118 124 2-s2.0-0032346168
33. Padberg F. T. Jr., Johnston M. V., Sisto S. A., Burnand K. G., Wakefield T. W., Perkowski P., Structured exercise improves calf muscle pump function in chronic venous insufficiency: a randomized trial. Journal of Vascular Surgery 2004 39 1 79 87 2-s2.0-0346334422 10.1016/j.jvs.2003.09.036 (Pubitemid 38056156)
34. Coccheri S., Scondotto G., Agnelli G., Aloisi D., Palazzini E., Zamboni V., Randomised, double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers. Thrombosis and Haemostasis 2002 87 6 947 952 2-s2.0-0036285389 (Pubitemid 34624874)
35. Kearon C., Kahn S. R., Agnelli G., Goldhaber S., Raskob G. E., Comerota A. J., Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008 133 6 454S 545S 2-s2.0-45949100970 10.1378/chest.08-0658 (Pubitemid 351892971)
36. Pesavento R., Villalta S., Prandoni P., The post-thrombotic syndrome. Internal and Emergency Medicine 2010 5 3 185 192